Healthscope (HSO) Stock Price, News & Analysis

Company Overview

Healthscope Limited provides healthcare services in Australia and New Zealand. The company operates through Hospitals Australia and Pathology New Zealand segments. It operates 43 private hospitals, including 30 acute hospitals, 7 mental health hospitals, and 6 rehabilitation hospitals with approximately 5,000 inpatient beds. The company also provides human pathology services under the Labtests, Southern Community Laboratories, and Northland Pathology brands; and veterinary and analytical pathology services under the Gribbles brand. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. and changed its name to Healthscope Limited in July 2014. Healthscope Limited was founded in 1985 and is headquartered in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 38.30 million shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 2.86%
• Price Target: N/A
• Consensus Rating: N/A

HSO Stock Analysis - Frequently Asked Questions

How were Healthscope's earnings last quarter?

Healthscope Ltd (ASX:HSO) announced its quarterly earnings results on Thursday, February, 14th. The company reported $0.04 earnings per share (EPS) for the quarter.

What other stocks do shareholders of Healthscope own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Healthscope investors own include UBS ETRACS CMCI Energy Total Return ETN (UBN), ResMed (RMD), Primary Health Care (PRY) and Fortescue (FMG).

Company Calendar

• Last Earnings: 2/14/2019
• Today: 9/15/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Hospitals
• Sub-Industry: N/A
• Current Symbol: ASX:HSO
• CIK: N/A
• Web: www.healthscope.com.au
• Phone: +61-3-99267500
• Fax: N/A
• Employees: 17,100
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,748,630,016
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A